An intramuscular injection delivers medication into a muscle. Doctors frequently use intramuscular injections to administer vaccines and certain other drugs. Injection sites include the upper arm, hip ...

The ventrogluteal injection site is an area on the most prominent part of the hip that's considered the preferred site for intramuscular injections. Experts say it's one of the safest areas for such ...

Most people know the feeling of getting a shot and having your arm feel sore for several days afterward. Some might even expect it as a side effect. The soreness happens when medications are injected ...

Ottawa, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The global human growth hormone injection market size is calculated at USD 4.82 billion in 2026 and is expected to reach around USD 8.54 billion by 2035, ...

Human growth hormone (HGH) therapy can help increase muscle mass, improve body composition, and boost energy in those experiencing low growth hormone levels due to underlying health conditions. HGH ...

A hormone treatment has been shown to lower obese individuals’ glucose levels and weight, and may prove a viable alternative to bariatric surgery. In a trial of obese, prediabetic patients, subjects ...

The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for children ...

A comparison of morning and evening growth hormone injection schedules in children with growth disorders showed no significant differences in sleep-wake patterns, sleep duration, or daytime activity, ...

Daily hormone injections helped dieters keep weight off in a study that helped shed light on why it is so easy to gain weight and so hard to keep it off, researchers said on Thursday. Their study ...

Growth hormone deficiency (GHD) is a rare condition. It can be congenital (present from birth), or a person can acquire it during childhood or adulthood. The age at which GHD presents may determine ...

A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.